Turkish Defense Ministry source: Syrian allies continue to advance in northern Syria to "eliminate terrorism".The monkeypox vaccine with independent intellectual property rights in China was approved for clinical use. On December 10th, the monkeypox vaccine jointly developed by China Bio-Beijing Institute of Biological Products and China Center for Disease Control and Prevention received the approval notice of drug clinical trial issued by National Medical Products Administration, and it was registered and classified as Class 1.2 innovative vaccine. The vaccine is an innovative vaccine independently developed by scientists in China with completely independent intellectual property rights, which is expected to play an important role in the prevention and control of diseases caused by monkeypox virus in China. (China Biology)Japan's Shimane nuclear power plant operating company said that there was no abnormality in the reactor water level gauge of Unit 2, which was previously misjudged. On December 12, local time, China Electric Power Company of Japan conducted an investigation on the report that the reactor water level gauge of Unit 2 of Shimane nuclear power plant was once abnormal, and the results showed that there was no abnormality. The company said that the value displayed by the instrument was normal, but the operator misunderstood the data and misjudged it as abnormal. (CCTV News)
Mengke Pharmaceutical Co., Ltd.: The new packaging of Contizontamide tablets will be on the market soon. Mengke Pharmaceutical Co., Ltd. announced that the company has launched Contizontamide tablets with new packaging specifications, and a box of 12 tablets will be on the market soon. Contizontamide tablet is a new class 1 oxazolidinone antibacterial drug with global intellectual property rights. It was approved by National Medical Products Administration, China on June 1st, 2021 for the treatment of complex skin and soft tissue infections.On the 12th, South Korea's National Assembly voted to pass a special civil strife inspection law to investigate President Yin Xiyue's suspicion of civil strife. (Xinhua News Agency)Adobe's US stocks fell about 9% before the market, and the company's annual performance guidance was worse than expected.
Zhongyuan Expressway: The toll revenue in November was 373 million yuan. Zhongyuan Expressway announced that the toll revenue in November 2024 was 373 million yuan.The monkeypox vaccine with independent intellectual property rights in China was approved for clinical use. On December 10th, the monkeypox vaccine jointly developed by China Bio-Beijing Institute of Biological Products and China Center for Disease Control and Prevention received the approval notice of drug clinical trial issued by National Medical Products Administration, and it was registered and classified as Class 1.2 innovative vaccine. The vaccine is an innovative vaccine independently developed by scientists in China with completely independent intellectual property rights, which is expected to play an important role in the prevention and control of diseases caused by monkeypox virus in China. (China Biology)Xiamen Tungsten Xinneng: Signed a strategic cooperation framework agreement for solid-state batteries with Xinwangda Power. Xiamen Tungsten Xinneng announced that the company and Xinwangda Power signed the Strategic Cooperation Framework Agreement for Solid-state Batteries on December 11, 2024. The two sides will give full play to their respective advantages in market and technology, promote the industrialization of a series of new energy battery materials for solid-state batteries, establish a deep-seated strategic cooperative relationship, jointly develop a series of new energy battery materials for solid-state batteries, and further expand business cooperation at an appropriate time.
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14